Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.
第一作者:
Kosuke,Saito
第一单位:
Division of Medical Safety Science, National Institute of Health Sciences, Setagaya, Tokyo 158-8501, Japan.
作者:
主题词
阿米替林(Amitriptyline);动物(Animals);胆管(Bile Ducts);色谱法, 液相(Chromatography, Liquid);氯米帕明(Clomipramine);判别分析(Discriminant Analysis);疾病模型, 动物(Disease Models, Animal);葡糖苷酰鞘氨醇类(Glucosylceramides);肝细胞(Hepatocytes);丙咪嗪(Imipramine);最小二乘法分析(Least-Squares Analysis);肝(Liver);溶血磷脂酰胆碱类(Lysophosphatidylcholines);溶酶体贮积病(Lysosomal Storage Diseases);男(雄)性(Male);质谱分析法(Mass Spectrometry);代谢组学(Metabolomics);多元分析(Multivariate Analysis);试验预期值(Predictive Value of Tests);大鼠(Rats)
DOI
10.1093/toxsci/kfu132
PMID
24980264
发布时间
2021-10-21
- 浏览7

Toxicological sciences
377-86页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文